A recent study from Gros et al. further demonstrated expression of PD-1 on CD8+ melanoma TILs identified the repertoire of clonally expanded tumor-reactive, mutation-specific lymphocytes and these populations played a critical role in tumor regression after adoptive cell therapy [28]. Here, PDCD1 is linked to melanoma.